Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection
Data up to Jan 2025
Total Citations Per Year
Abstract
References (47)
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
1998 • 9,382 citations
Cost-Effectiveness in Health and Medicine
1996 • 6,853 citations
Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
2000 • 3,295 citations
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
1997 • 2,670 citations
Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection
1997 • 2,097 citations
Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults
1999 • 1,008 citations
Effectiveness of Interventions to Improve Patient Compliance
1998 • 1,008 citations
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS
2001 • 947 citations
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study
1999 • 937 citations
Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug Reactions
1999 • 850 citations
A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients
1998 • 777 citations
A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors
2001 • 771 citations
Deriving a Preference-Based Single Index from the UK SF-36 Health Survey
1998 • 677 citations
The Care of HIV-Infected Adults in the United States
1998 • 537 citations
The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease
2001 • 506 citations
A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy
2000 • 499 citations
USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus: Disease-Specific Recommendations*
1995 • 425 citations
Impact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV-Infected Patients
2002 • 419 citations
Two Controlled Trials of Rifabutin Prophylaxis against Mycobacterium avium Complex Infection in AIDS
1993 • 396 citations
Mechanisms of Virologic Failure in Previously Untreated HIV-Infected Patients From a Trial of Induction-Maintenance Therapy
2000 • 376 citations
Prophylaxis against DisseminatedMycobacterium aviumComplex with Weekly Azithromycin, Daily Rifabutin, or Both
1996 • 334 citations
Two strategies to increase adherence to HIV antiretroviral medication: Life-Steps and medication monitoring
2001 • 320 citations
Adherence in AIDS clinical trials: A framework for clinical research and clinical care
1997 • 304 citations
Expenditures for the Care of HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy
2001 • 272 citations
Limited Patient Adherence to Highly Active Antiretroviral Therapy for HIV-1 Infection in an Observational Cohort Study
2001 • 258 citations
Prospective Randomized Two-Arm Controlled Study To Determine the Efficacy of a Specific Intervention To Improve Long-Term Adherence to Highly Active Antiretroviral Therapy
2000 • 251 citations
Simultaneous vs Sequential Initiation of Therapy With Indinavir, Zidovudine, and Lamivudine for HIV-1 Infection
1998 • 243 citations
Use of Genotypic Resistance Testing To Guide HIV Therapy: Clinical Impact and Cost-Effectiveness
2001 • 238 citations
Updates of Cost of Illness and Quality of Life Estimates for Use in Economic Evaluations of HIV Prevention Programs
1997 • 235 citations
Effect of adherence to newly initiated antiretroviral therapy on plasma viral load
2001 • 219 citations
Cue-dose training with monetary reinforcement
2000 • 209 citations
3-Year Suppression of HIV Viremia with Indinavir, Zidovudine, and Lamivudine
2000 • 205 citations
A Meta-analysis of the Relative Efficacy and Toxicity of Pneumocystis carinii Prophylactic Regimens
1996 • 186 citations
Atovaquone Compared with Dapsone for the Prevention ofPneumocystis cariniiPneumonia in Patients with HIV Infection Who Cannot Tolerate Trimethoprim, Sulfonamides, or Both
1998 • 173 citations
Adherence to Highly Active Antiretroviral Therapy Predicts Virologic Outcome at an Inner‐City Human Immunodeficiency Virus Clinic
2001 • 154 citations
Comparison of Health State Utilities Using Community and Patient Preference Weights Derived from a Survey of Patients with HIV/AIDS
2002 • 105 citations
Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis.
1996 • 104 citations
A Randomized Trial of Daily and Thrice‐Weekly Trimethoprim‐Sulfamethoxazole for the Prevention ofPneumocystis cariniiPneumonia in Human Immunodeficiency Virus‐Infected Persons
1999 • 97 citations
A Cost-effectiveness Analysis of Directly Observed Therapy vs Self-administered Therapy for Treatment of Tuberculosis
1997 • 84 citations
Home-based Management Can Achieve Intensification Cost-effectively in Type I Diabetes
1999 • 57 citations
Cost-Effectiveness of Outpatient Geriatric Assessment With an Intervention to Increase Adherence
1999 • 48 citations
Public Health Consequences of Screening Patients for Adherence to Highly Active Antiretroviral Therapy
2001 • 29 citations
Preevaluation of Clinical Trial Data: The Case of Preemptive Cytomegalovirus Therapy in Patients with Human Immunodeficiency Virus
2001 • 27 citations
Public Health Consequences of Screening Patients for Adherence to Highly Active Antiretroviral Therapy
2001 • 20 citations
A Model of the Cost-Effectiveness of Directly Observed Therapy for Treatment of Tuberculosis
1998 • 15 citations
Adherence and health care utilization in HIV/AIDS-rational or rationalizing?
2000 • 5 citations
HIV adherence strategies take a high-tech route.
2001 • 3 citations